Orchid Labs is raising $125 million in a SAFT sale, filings from the Securities and Exchange Commission (SEC) reveal.
According to a Form D published on April 20, Orchid has raised roughly $36.1 million out of a planned $125.59 million. Per the Form D filing, 42 investors have taken part in the sale of SAFTs – or Simple Agreements for Future Tokens – thus far. The SAFT gives accredited investors the right to claim blockchain tokens at a later date, and the investors involved must meet certain SEC-mandated income or asset thresholds in order to participate.
The startup is seeking to build an alternative to Tor, the anonymous browser software – Orchid's white paper argues that Tor can be compromised due to a lack of network nodes. It also aims to provide an alternative to virtual private networks (VPN), which require users to trust the provider.
Orchid's solution allows bandwidth users and providers to exchange ethereum-based Orchid tokens, which the firm hopes will incentivize greater participation than the Tor network has enjoyed. By executing these micropayments through the ethereum blockchain, Orchid has designed its network to be decentralized, in contrast to VPNs.
The firm raised $4.7 million in October from a raft of top-tier venture capital firms, including Andreessen Horowitz, Blockchain Capital, Polychain Capital and Sequoia.
Orchid's co-founder and CEO Steven Waterhouse told CoinDesk at the time:
Waterhouse told CoinDesk in October that his focus on private internet browsing began with the personal experience of being hacked.
"That really woke me up," he said.
Orchid image via Shutterstock.
The leader in news and information on cryptocurrency, digital assets and the future of money, CoinDesk is a media outlet that strives for the highest journalistic standards and abides by a strict set of editorial policies. CoinDesk is an independent operating subsidiary of Digital Currency Group, which invests in cryptocurrencies and blockchain startups. As part of their compensation, certain CoinDesk employees, including editorial employees, may receive exposure to DCG equity in the form of stock appreciation rights, which vest over a multi-year period. CoinDesk journalists are not allowed to purchase stock outright in DCG.